These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24305957)

  • 1. Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
    Cheng N; Lee SK; Donover PS; Reichman M; Schiffer CA; Hull-Ryde EA; Swanstrom R; Janzen WP
    J Lab Autom; 2014 Jun; 19(3):297-303. PubMed ID: 24305957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
    Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
    J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease.
    Breuer S; Sepulveda H; Chen Y; Trotter J; Torbett BE
    Biochemistry; 2011 May; 50(20):4371-81. PubMed ID: 21452835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
    Lee SK; Cheng N; Hull-Ryde E; Potempa M; Schiffer CA; Janzen W; Swanstrom R
    Biochemistry; 2013 Jul; 52(29):4929-40. PubMed ID: 23763575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.
    Lee SK; Harris J; Swanstrom R
    J Virol; 2009 Sep; 83(17):8536-43. PubMed ID: 19515760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
    Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
    Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protease-substrate coevolution in nelfinavir resistance.
    Kolli M; Ozen A; Kurt-Yilmaz N; Schiffer CA
    J Virol; 2014 Jul; 88(13):7145-54. PubMed ID: 24719428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and application of a high-throughput screening assay for premature activation of HIV-1 precursors].
    Zhang Q; Li XY; Liu ZL; Jia PP; Wei XL; Zhao LX; Jiang JD; Cen S
    Yao Xue Xue Bao; 2010 Feb; 45(2):247-52. PubMed ID: 21351435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.
    Nangola S; Urvoas A; Valerio-Lepiniec M; Khamaikawin W; Sakkhachornphop S; Hong SS; Boulanger P; Minard P; Tayapiwatana C
    Retrovirology; 2012 Feb; 9():17. PubMed ID: 22348230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
    Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
    J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S; Louis JM; Tycko R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease cleavage leads to formation of mature trimer interface in HIV-1 capsid.
    Meng X; Zhao G; Yufenyuy E; Ke D; Ning J; Delucia M; Ahn J; Gronenborn AM; Aiken C; Zhang P
    PLoS Pathog; 2012; 8(8):e1002886. PubMed ID: 22927821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs.
    Su CT; Koh DW; Gan SK
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
    Fun A; van Maarseveen NM; Pokorná J; Maas RE; Schipper PJ; Konvalinka J; Nijhuis M
    Retrovirology; 2011 Aug; 8():70. PubMed ID: 21864346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.